Literature DB >> 3496659

The diagnosis of schizophrenia.

N C Andreasen.   

Abstract

Diagnosis refers to developing the best methods for classifying disorders and for identifying their characteristic symptoms. Most importantly, however, diagnosis refers to the identification of particular disorders that differ in their underlying mechanisms and causes, and therefore defines them as discrete diseases. Most current work on schizophrenia attempts to identify the best ways to classify it and the best ways to identify and define its characteristic symptoms to improve the ongoing search for mechanisms and causes. One idea that is currently widely discussed is the distinction between positive or florid symptoms and negative or defect symptoms. Much more research needs to be done on this model, however, and we need many more studies that attempt to integrate biological research with the careful work that has been done to date on clinical description. The astute modern investigator must be able to move freely between the biotype and the phenomenotype if he or she is to understand fully the clinical picture and ultimately the cause of schizophrenia.

Entities:  

Mesh:

Year:  1987        PMID: 3496659     DOI: 10.1093/schbul/13.1.9

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  10 in total

1.  Childhood onset schizophrenia: high rate of visual hallucinations.

Authors:  Christopher N David; Deanna Greenstein; Liv Clasen; Pete Gochman; Rachel Miller; Julia W Tossell; Anand A Mattai; Nitin Gogtay; Judith L Rapoport
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2011-06-11       Impact factor: 8.829

Review 2.  Schizophrenia epigenesis?

Authors:  J S Robert
Journal:  Theor Med Bioeth       Date:  2000

3.  Famotidine as an adjunct treatment of resistant schizophrenia.

Authors:  L K Oyewumi; D Vollick; H Merskey; C Plumb
Journal:  J Psychiatry Neurosci       Date:  1994-03       Impact factor: 6.186

4.  Personality and Psychopathology: a Theory-Based Revision of Eysenck's PEN Model.

Authors:  Dirk van Kampen
Journal:  Clin Pract Epidemiol Ment Health       Date:  2009-12-08

5.  A prospective study of daily stressors and symptomatology in schizophrenic patients.

Authors:  R M Norman; A K Malla
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1994-11       Impact factor: 4.328

Review 6.  Religious psychopathology: The prevalence of religious content of delusions and hallucinations in mental disorder.

Authors:  Christopher C H Cook
Journal:  Int J Soc Psychiatry       Date:  2015-03-12

7.  Reducing the Schizophrenia Stigma: A New Approach Based on Augmented Reality.

Authors:  Rafael D de C Silva; Saulo G C Albuquerque; Artur de V Muniz; Pedro P Rebouças Filho; Sidarta Ribeiro; Plácido Rogerio Pinheiro; Victor Hugo C Albuquerque
Journal:  Comput Intell Neurosci       Date:  2017-11-29

8.  Psychosis Biotypes: Replication and Validation from the B-SNIP Consortium.

Authors:  Brett A Clementz; David A Parker; Rebekah L Trotti; Jennifer E McDowell; Sarah K Keedy; Matcheri S Keshavan; Godfrey D Pearlson; Elliot S Gershon; Elena I Ivleva; Ling-Yu Huang; S Kristian Hill; John A Sweeney; Olivia Thomas; Matthew Hudgens-Haney; Robert D Gibbons; Carol A Tamminga
Journal:  Schizophr Bull       Date:  2022-01-21       Impact factor: 9.306

9.  Novel research translates to clinical cases of schizophrenic and cocaine psychosis.

Authors:  João V Nunes; Patricia A Broderick
Journal:  Neuropsychiatr Dis Treat       Date:  2007-08       Impact factor: 2.570

10.  Mismatch Negativity and P3a Impairment through Different Phases of Schizophrenia and Their Association with Real-Life Functioning.

Authors:  Giulia M Giordano; Luigi Giuliani; Andrea Perrottelli; Paola Bucci; Giorgio Di Lorenzo; Alberto Siracusano; Francesco Brando; Pasquale Pezzella; Michele Fabrazzo; Mario Altamura; Antonello Bellomo; Giammarco Cascino; Anna Comparelli; Palmiero Monteleone; Maurizio Pompili; Silvana Galderisi; Mario Maj
Journal:  J Clin Med       Date:  2021-12-13       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.